Drug makers must prove their value to doctors
As the U.S. health care system moves toward one that pays for value, not simply for treatments, drug companies must give physicians more tools to measure their drug's effectiveness if they want those same physicians to prescribe their medicines.
Read: Triangle panel agrees: Better incentives needed to keep Americans healthy
Consider two basically equivalent blood pressure treatments. If drug company A offers a companion product that allows doctors to more easily track its health bene...